GlaxoSmithKline PLC

Healthcare · Drug Manufacturers - General

50.50$ -0.4% vs. previous close Closing price · As of: Nov 13, 2026

Statements

Balance Sheet

GlaxoSmithKline PLC (GSK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q3 26), "Total Assets" came in at 72,179 million GBP. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of GBP.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GSK
Line item	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26
Total Assets	75,220	73,914	73,401	58,049	59,463	78,355	81,204	82,578	61,118	82,905	61,365	72,179
Current Assets	23,767	21,734	21,191	17,298	16,997	23,343	24,218	24,020	17,510	23,421	17,453	18,015
Cash	3,743	3,524	3,744	3,192	3,693	5,762	4,932	4,437	3,397	4,539	3,086	2,954
Cash & Short-Term Investments	6,606	5,173	3,771	3,212	3,714	5,789	4,959	4,451	3,400	4,540	3,087	2,982
Receivables	9,437	9,210	9,832	7,383	5,999	9,682	10,548	11,179	7,471	10,467	8,025	8,582
Inventory	7,009	7,203	7,406	5,918	5,669	7,745	8,321	8,236	5,924	8,119	6,244	6,342
Property, Plant & Equipment	–	–	–	9,725	10,073	9,971	9,918	10,132	10,048	–	–	–
Goodwill	8,683	8,815	8,798	6,680	6,982	8,940	9,228	9,581	7,018	9,609	7,336	8,271
Intangible Assets	18,826	19,791	19,559	15,010	15,515	20,985	21,071	22,705	16,748	23,919	16,701	25,341
Total Liabilities	58,909	57,202	55,995	44,596	46,377	60,731	61,534	61,371	45,162	59,931	44,292	53,694
Current Liabilities	26,857	25,070	25,718	21,459	21,697	26,888	27,925	28,721	21,391	29,577	21,404	20,859
Short-Term Debt	3,586	3,305	4,255	2,815	2,349	2,527	2,809	3,845	3,012	6,652	4,265	2,014
Accounts Payable	20,198	18,470	18,007	14,375	3,462	19,554	20,309	15,675	15,381	18,904	14,255	15,738
Long-Term Debt	14,154	–	–	13,244	13,703	16,474	15,304	14,894	14,015	–	–	–
Shareholders' Equity	17,015	17,483	18,168	14,008	13,671	18,273	20,269	21,739	16,377	23,541	17,538	18,880
Retained Earnings	9,228	10,024	10,850	8,187	7,796	10,722	12,055	13,484	10,209	15,284	11,395	12,541
Shares Outstanding	2,059	2,057	2,061	2,040	2,073	2,069	2,055	2,051	2,043	2,037	2,031	2,037

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings